Prostate Cancer Medicines

Product Description

Prostate Cancer Medicines

Hormone Therapy for Prostate Cancer. Primary Hormone Therapy Since serves as the main fuel for prostate cancer cell growth, its a common target for treatment. Primary hormone therapy (also called androgen deprivation therapy or ADT) is part of the standard of care for advanced metastatic prostate cancer.

• Abiraterone Acetate
• Apalutamide
• Bicalutamide
• Cabazitaxel
• Casodex (Bicalutamide)
• Degarelix
• Docetaxel
• Eligard (Leuprolide Acetate)
• Enzalutamide
• Erleada (Apalutamide)
• Firmagon (Degarelix)
• Flutamide
• Goserelin Acetate
• Jevtana (Cabazitaxel)
• Leuprolide Acetate
• Lupron (Leuprolide Acetate)
• Mitoxantrone Hydrochloride
• Nilandron (Nilutamide)
• Nilutamide
• Provenge (Sipuleucel-T)
• Radium 223 Dichloride
• Sipuleucel-T
• Taxotere (Docetaxel)
• Xofigo (Radium 223 Dichloride)
• Xtandi (Enzalutamide)
• Zoladex (Goserelin Acetate)
• Zytiga (Abiraterone Acetate)

We offers all above prostate cancer medication on affordabel rate with good quality.


Targeted Therapy for Advanced Prostate Cancer

Abiraterone Acetate works by inhibiting the CYP17 enzyme involved in androgen production, making it an effective oral therapy for metastatic or advanced prostate cancer. Its targeted action helps reduce tumor growth and improves patient survival when combined with other cancer treatments, offering renewed hope in oncology practice.


Convenient Oral Administration and Packaging

Each bottle contains 120 tablets to support ongoing therapy. The uncoated, white to off-white tablets are administered orally, making them easy for patients to manage at home. The HDPE bottle packaging ensures safe storage and maintains the quality of the tablets during the shelf life.